18-62325368-C-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_003839.4(TNFRSF11A):āc.16C>Gā(p.Arg6Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000767 in 1,043,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_003839.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF11A | NM_003839.4 | c.16C>G | p.Arg6Gly | missense_variant | 1/10 | ENST00000586569.3 | NP_003830.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFRSF11A | ENST00000586569.3 | c.16C>G | p.Arg6Gly | missense_variant | 1/10 | 1 | NM_003839.4 | ENSP00000465500.1 | ||
TNFRSF11A | ENST00000269485.11 | c.16C>G | p.Arg6Gly | missense_variant | 1/7 | 1 | ENSP00000269485.7 | |||
TNFRSF11A | ENST00000592013.1 | n.43C>G | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000475 AC: 7AN: 147448Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000112 AC: 1AN: 895604Hom.: 0 Cov.: 30 AF XY: 0.00000236 AC XY: 1AN XY: 422902
GnomAD4 genome AF: 0.0000475 AC: 7AN: 147448Hom.: 0 Cov.: 32 AF XY: 0.0000418 AC XY: 3AN XY: 71790
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.16C>G (p.R6G) alteration is located in exon 1 (coding exon 1) of the TNFRSF11A gene. This alteration results from a C to G substitution at nucleotide position 16, causing the arginine (R) at amino acid position 6 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 6 of the TNFRSF11A protein (p.Arg6Gly). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with TNFRSF11A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1928932). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at